Saturday, June 23, 2007
The Science of Taking Life Industry
The connection between current "life science" corporations and warfare should be fairly well known,
DuPont,
Dow,
Monsanto - now major companies involved in seed production and agri-chemicals. Well, that history isn't over. According to a
recent editorial, the work of many "life science" companies in the arena of biowarfare research isn't being made public, despite legal requirements for NIH funded research.
Some of the companies in question: Abbott Laboratories, BASF Plant Science, Bristol-Myers Squibb, DuPont Central Research and Development, Eli Lilly Corp., Embrex, GlaxoSmithKline, Hoffman-LaRoche, Merck & Co., Monsanto, Pfizer Inc., Schering-Plough Research Institute, and Syngenta Corp. of Switzerland.
Quoting
Sunshine Project reports and University of Illinois, Urbana-Champaign international law scholar Francis Boyle, the editorial drops the following info:
- The Bush Administration has called for $44 billion for biowarfare research, apparently this is more than in any other time in history
- Only 8,500 (16%) of the 52,000 workers at the top 20 US biotech firms work as NIH guidelines-compliant facilities
- the Pentagon's Chemical and Biological Defense Program has been revised (as of 2003) to include offensive strikes
- the NIH received $1.76 billion for biodefense (mostly for anthrax research), while it only received $120 million to combat influenza, which kills around 36,000 US citizens annually.
Monday, June 18, 2007
The Dark Matter of DNA
From
Biology News Net:
Not so long ago, the difficult-to-sequence, highly repetitive, gene-poor DNA found in regions of chromosomes known as heterochromatin was called "junk." Like dark matter in the universe, the true nature of heterochromatin was unknown.
The FDA (or Freemarket Drug Administration)
The connections between our food and drug regulating bodies, namely the FDA, and corporate interests probably get most of us upset, as we think we know a conflict of interest when we see it. But, for investors, it's all in a day's work. Just look at
this commentary on the connections between the FDA drug approval process and stock success.
Sunday, June 03, 2007
Canadian Bill Would Extend Ban of Terminator Seeds
A
bill introduced into the Canadian Parliament on May 31 would place Canada in line with Brazil and India in their efforts to refute the efforts of agri-biotech companies to produce patented lines of seeds that cannot reproduce. The UN has already recommended a moratorian on field testing and sale of seeds using this technology initially developed by the USDA along with multi-nationals like Monsanto.
For more on the Canadian and global effort to stop Terminator tech, see the
Ban Terminator site.
If You Build It (out of DNA), They Will Come (with money)
OK, forget SynBio (that's Synthetic Biology, for newbies), now there's
Constructive Biology. What is constructive biology, you ask? Well, it's a trademarked neologism that a start up named
Codon Devices (Cambridge, MA based privately held company founded in 2004) is using to position themselves as the avant garde in biotech.
With the US even beginning to acknowledge the coming energy crisis, and frantically proposing
solutions that would least alter overconsumption, and the bio/nano tech industry is already
positioning itself as a savior.
More Pharming News
Biotech corporation Ventria Biosciences, has planted
a rice containing two human breast milk proteins that will be used as a treatment for diarrhea and as an additive to infant formulas, yogurt, granola bars and sports drinks.
The rice has been planted in Kansas under permission from the Bush Administration, despite the 20,005 "
against" to 29 "for" public comments the USDA received about the issue.
Gene Doping
The
New York Times has a piece on the potential for gene therapy in the realm of athletic medicine and performance-enhancing. Of course, if something is going to drive gene therapy, it only makes sense that it would the spectacle of sports.
Archives
June 2004
July 2004
August 2004
September 2004
October 2004
November 2004
December 2004
January 2005
February 2005
March 2005
April 2005
May 2005
June 2005
July 2005
August 2005
September 2005
October 2005
November 2005
December 2005
January 2006
February 2006
March 2006
April 2006
May 2006
June 2006
July 2006
August 2006
September 2006
October 2006
November 2006
December 2006
January 2007
February 2007
March 2007
April 2007
May 2007
June 2007
July 2007
syndicate [atom]
preBlog archives
